NCT07389187 2026-02-05
Safety and Preliminary Efficacy Evaluation of LC-K76 Plus Anti-PD-1 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Shanghai Changzheng Hospital
Phase EARLY_PHASE1 Not yet recruiting
Clinical Trials
3 trialsNCT07096128 2025-07-31
A Study of [177Lu] Lu-PSMA-XT Injection in Patients With Metastatic Prostate Cancer
Chinese PLA General Hospital
Phase 1 Recruiting
NCT06830408 2025-02-17
Performance of 177Lu-PSMA-I&T for RLT in mCRPC - Prospective Multicenter Swiss Registry Study
University Hospital, Basel, Switzerland
Completed